Brief: Bio-Rad Q4 Adjusted EPS USD 3.1 Vs. IBES Estimate USD 2.82
15/02/2024 21:15
Feb 15 (Reuters) - Bio-Rad Q4 EPS USD 12.14. * Q4 sales USD 681.2 million vs. IBES estimate USD 685.1 million * Q4 EBIT margin 14% * Q4 net income USD 349.7 million * Q4 gross margin 53.8%
Recent news on Bio-Rad Laboratories
See all newsBio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Bio-Rad Laboratories On July 31, Initiated Restructuring Plan - SEC Filing
Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth
Brief: Bio-Rad Q2 Net Income USD 371.4 Million
Activist investors make bigger push for campaigns in H1, seek more M&A